Europe Needle-free IV Connectors Market Analysis-2027

1. EUROPE NEEDLE-FREE IV CONNECTORS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Europe Needle-free IV Connectors Market - Overview Europe Needle-free IV Connectors Market, by Design Type (Straight Channel, T-channel, Y- channel, and Multi-channel), by Mechanism (Positive Fluid Displacement, Negative Fluid Displacement, and Neutral Fluid Displacement), by Dwell Time (Seven Day and Other than Seven Day), and by Country (Germany, U.K., France, Italy, Spain, Russia, Denmark, Sweden, Poland, and Rest of Europe), is estimated to be valued at US$ 246.2 million in 2020 and is expected to exhibit a CAGR of 8.7% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. Key companies are focusing on inorganic strategies such as mergers and acquisitions to strengthen their position in the Europe needle-free IV connectors market. For instance, in 2017 ICU Medical Inc. acquired Hospira Infusion Systems business from Pfizer Inc. Hospira Infusion Systems business include IV pumps, solutions, and devices. The acquisition aided ICU Medical to strengthen its position in the needle-free IV connectors market in Europe. Moreover, key companies are focusing on strategies such as collaborations and acquisitions, in the Europe needle-free IV connectors market. For instance, in 2017, Cardinal Health, Inc. acquired patient recovery business from Medtronic for US$ 6.1 billion in cash. Thus due to this government initiatives, European small and large medical device companies can comfortably combat the debt issues faced by companies in COVID-19 pandemic Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/europe- needle-free-iv-connectors-market-4261 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Europe Needle-free IV Connectors Market – Impact of Coronavirus (COVID-19) The COVID-19 pandemic has affected several markets across the globe and is also expected to hamper demand and supply of needle-free IV connectors in Europe. The COVID-19 pandemic has affected Europe needle-free IV connectors market in three main ways; by directly affecting the production and demand; by creating disruptions in distribution channels; and by its financial impact on firms and financial markets. Moreover, European government are taking initiatives to combat COVID-19 crisis are expected to drive the market growth during the forecast period. For instance, according to European Association of Guarantee Institutions report published in May 2020, German government announced the possibility to ask for a loan backed by the German government (80/90%) of up to US$ 1.17 Billion capped at 25% of the annual turnover to cover liquidity needs for the next 18 months for small companies or 12 months for large companies or is companies have 50% of the overall debt such as loan is more than of EUR 25 million. Browse 40 Market Data Tables and 29 Figures spread through 193 Pages and in-depth TOC on “Europe Needle-free IV Connectors Market, by Design Type (Straight Channel, T-channel, Y- channel, and Multi-channel), by Mechanism (Positive Fluid Displacement, Negative Fluid Displacement, and Neutral Fluid Displacement), by Dwell Time (Seven Day and Other than Seven Day ), and by Country (Germany, U.K., France, Italy, Spain, Russia, Denmark, Sweden, Poland, and Rest of Europe).” Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4261 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION The major factors driving growth of the global interferon beta drugs market include an increasing number of research and development activities, approval and launch of novel drug candidates and the rising prevalence of the multiple sclerosis in children. For instance, in 2014, Plegridy (peginterferon beta-1a), a disease modifying therapy, was approved by the U.S. Food and Drug Administration for the long-term treatment of relapsing forms of multiple sclerosis. According to Multiple Sclerosis Society, around 5-10% of people with MS experienced their first symptoms before the age of 16. Key Takeaways of the Global Interferon Beta Drugs Market: The global interferon beta drugs market is expected to exhibit a CAGR of 3.5% during the forecast period due to an increasing number of research and development activities by biotechnology companies. On the basis of product type, the interferon beta-1a segment holds a dominant position in the global interferon beta drugs market due to availability of a large number of drugs in the interferon beta-1a category. On the basis of route of administration, intramuscular segment holds a dominant position in the global interferon beta drugs market. Key players operating in the global interferon beta drugs market are Biogen Idec., Merck KGaA, Novartis Pharmaceuticals Corporation, and Bayer. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4261 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved